Search Orphan Drug Designations and Approvals
-
Generic Name: | Botulinum toxin type A |
---|---|
Date Designated: | 09/15/1992 |
Orphan Designation: | Treatment of synkinetic closure of the eyelid associated with VII cranial nerve aberrant regeneration. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Botulinum Toxin Research Associates, Inc. 1261 Furnace Brook Parkway Quincy, Massachusetts 02169 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-